Veterinary Vaccines Market Report by Vaccine Type, Technology, Route of Administration, Distribution Channel, and Region 2024-2032

Description

List of Tables

The global veterinary vaccines market size reached US$ 13.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.0 Billion by 2032, exhibiting a growth rate (CAGR) of 8.12% during 2024-2032.

Veterinary vaccines represent bio-prepared immunizations that are administered to domestic animals or wild species through parenteral and oral routes to stimulate protective immune responses without causing the disease itself. They involve inactivated, live attenuated and recombinant vaccines as some common medications. These inoculations aid in reducing animal suffering, enhancing immune efficiency, and preventing the risk of developing and transmitting various contagious zoonotic diseases. Apart from this, veterinary vaccines are cost-effective, reliable, and offer long-term prevention, due to which they are also used to increase the production of livestock across the globe.

Veterinary Vaccines Market Trends:

The global veterinary vaccines market is majorly driven by the increasing demand for effective immunization products and the rising prevalence of various infectious epizootic disorders. This can be further attributed to the domestication of both companion and livestock animals across the globe and the enhanced focus on pet health. In line with this, extensive investments by governments in the pharmaceutical sector to improve novel veterinary vaccine manufacturing procedures are acting as another growth-inducing factor. Additionally, the introduction of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) vaccines with improved product stability, efficacy, and route administration approach is contributing to the market growth. Besides this, the innovation of intramuscular needle-free vaccine injections and growing awareness amongst consumers regarding their beneficial properties, such as enhanced safety and less pain, is propelling the market growth. Moreover, the fueling need for veterinary vaccines to prevent the transmission of disease-carrying microbes from livestock-based products, including milk, meat, leather, eggs, and wool, is positively stimulating the market growth. Other factors, such as significant improvements in the healthcare infrastructure, ongoing research and development (R&D) activities, and strategic collaborations amongst key players to enhance the efficiency of veterinary vaccines, are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary vaccines market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on vaccine type, technology, route of administration and distribution channel.

Breakup by Vaccine Type:

Livestock Vaccines

Bovine Vaccines

Poultry Vaccines

Porcine Vaccines

Others

Companion Animal Vaccines

Canine Vaccines

Feline Vaccines

Equine Vaccines

Breakup by Technology:

Attenuated Live Vaccines

Inactivated Vaccines

Toxoid Vaccines

Recombinant Vaccines

Others

Breakup by Route of Administration:

Subcutaneous

Intramuscular

Intranasal

Breakup by Distribution Channel:

Veterinary Hospitals

Veterinary Clinics

Pharmacies and Drug Stores

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Incorporated, Hester Biosciences Limited, HIPRA, Indian Immunologicals Limited, Merck & Co. Inc., Neogen Corporation, Phibro Animal Health Corporation, Virbac SA and Zoetis Inc.

Key Questions Answered in This Report:

How has the global veterinary vaccines market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global veterinary vaccines market?
What are the key regional markets?
What is the breakup of the market based on the vaccine type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global veterinary vaccines market and who are the key players?
What is the degree of competition in the industry?

Product Code: SR112024A6493

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Veterinary Vaccines Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Vaccine Type

6.1 Livestock Vaccines
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Bovine Vaccines
  - 6.1.2.2 Poultry Vaccines
  - 6.1.2.3 Porcine Vaccines
  - 6.1.2.4 Others
- 6.1.3 Market Forecast
6.2 Companion Animal Vaccines
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Canine Vaccines
  - 6.2.2.2 Feline Vaccines
  - 6.2.2.3 Equine Vaccines
- 6.2.3 Market Forecast

7 Market Breakup by Technology

7.1 Attenuated Live Vaccines
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Inactivated Vaccines
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Toxoid Vaccines
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Recombinant Vaccines
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Route of Administration

8.1 Subcutaneous
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Intramuscular
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Intranasal
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Veterinary Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Veterinary Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Pharmacies and Drug Stores
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Boehringer Ingelheim International GmbH
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 Ceva Sante Animale
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Elanco Animal Health Incorporated
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
- 15.3.4 Hester Biosciences Limited
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
- 15.3.5 HIPRA
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Indian Immunologicals Limited
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Merck & Co. Inc.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
- 15.3.8 Neogen Corporation
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Phibro Animal Health Corporation
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Virbac SA
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
- 15.3.11 Zoetis Inc.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials

Product Code: SR112024A6493

List of Figures

Figure 1: Global: Veterinary Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Veterinary Vaccines Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Veterinary Vaccines Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Veterinary Vaccines Market: Breakup by Vaccine Type (in %), 2023
Figure 5: Global: Veterinary Vaccines Market: Breakup by Technology (in %), 2023
Figure 6: Global: Veterinary Vaccines Market: Breakup by Route of Administration (in %), 2023
Figure 7: Global: Veterinary Vaccines Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Veterinary Vaccines Market: Breakup by Region (in %), 2023
Figure 9: Global: Veterinary Vaccines (Livestock Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Veterinary Vaccines (Livestock Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Veterinary Vaccines (Companion Animal Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Veterinary Vaccines (Companion Animal Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Veterinary Vaccines (Inactivated Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Veterinary Vaccines (Inactivated Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Veterinary Vaccines (Toxoid Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Veterinary Vaccines (Toxoid Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Veterinary Vaccines (Recombinant Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Veterinary Vaccines (Recombinant Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Veterinary Vaccines (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Veterinary Vaccines (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Veterinary Vaccines (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Veterinary Vaccines (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Veterinary Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Veterinary Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Veterinary Vaccines (Intranasal) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Veterinary Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Veterinary Vaccines (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Veterinary Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Veterinary Vaccines (Veterinary Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Veterinary Vaccines (Veterinary Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Veterinary Vaccines (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Veterinary Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Veterinary Vaccines Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Veterinary Vaccines Industry: SWOT Analysis
Figure 87: Global: Veterinary Vaccines Industry: Value Chain Analysis
Figure 88: Global: Veterinary Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Veterinary Vaccines Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Veterinary Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2024-2032
Table 3: Global: Veterinary Vaccines Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Veterinary Vaccines Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 5: Global: Veterinary Vaccines Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Veterinary Vaccines Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Veterinary Vaccines Market: Competitive Structure
Table 8: Global: Veterinary Vaccines Market: Key Players

Veterinary Vaccines Market Report by Vaccine Type, Technology, Route of Administration, Distribution Channel, and Region 2024-2032

Description

Table of Contents

List of Tables

Veterinary Vaccines Market Trends:

Key Market Segmentation:

Breakup by Vaccine Type:

Breakup by Technology:

Breakup by Route of Administration:

Breakup by Distribution Channel:

Breakup by Region:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Veterinary Vaccines Market

6 Market Breakup by Vaccine Type

7 Market Breakup by Technology

8 Market Breakup by Route of Administration

9 Market Breakup by Distribution Channel

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

List of Figures

List of Tables